VIVO Historical PE Ratio image   This VIVO PE ratio history page last updated 2/7/2023
VIVO PE History Chart
PeriodPriceAdj. EPSTTMPE
Q4 2022
11/22/2022
31.770.201.3723.2
Q3 2022
8/5/2022
32.500.161.4023.2
Q2 2022
5/6/2022
26.220.661.4618.0
Q1 2022
2/4/2022
23.980.351.3617.6
Q4 2021
11/12/2021
20.730.231.6612.5
Q3 2021
8/6/2021
20.630.221.6212.7
Q2 2021
5/7/2021
20.450.561.9510.5
Q1 2021
2/5/2021
29.020.651.6217.9
Q4 2020
11/13/2020
16.920.191.0715.8
Q3 2020
8/7/2020
19.320.551.0119.1
Q2 2020
5/8/2020
17.490.230.6228.2
Q1 2020
2/7/2020
7.800.100.5813.4
Q4 2019
11/7/2019
8.250.130.6812.1
Q3 2019
7/30/2019
11.980.160.7516.0
Q2 2019
4/30/2019
11.510.190.7714.9
Q1 2019
1/24/2019
16.970.200.7921.5
Q4 2018
11/8/2018
19.630.200.7426.5
Q3 2018
7/31/2018
15.800.180.6922.9
Q2 2018
4/26/2018
14.900.210.6722.2
Q1 2018
1/25/2018
16.200.150.6823.8
Q4 2017
11/9/2017
14.800.150.6821.8
Q3 2017
7/27/2017
14.650.160.6721.9
Q2 2017
4/27/2017
15.000.220.7220.8
Q1 2017
1/25/2017
12.800.150.7417.3
Q4 2016
11/10/2016
17.050.140.8021.3
Q3 2016
7/28/2016
20.000.210.8623.3
Q2 2016
4/28/2016
19.850.240.8722.8
Q1 2016
1/27/2016
18.640.210.8721.4
Q4 2015
11/5/2015
19.950.200.8523.5
Q3 2015
7/23/2015
18.670.220.8522.0
Q2 2015
4/23/2015
18.800.240.8422.4
Q1 2015
1/22/2015
17.340.190.8420.6
Q4 2014
11/6/2014
17.910.200.8321.6
Q3 2014
7/24/2014
20.040.210.8523.6
Q2 2014
4/24/2014
20.570.240.8823.4
Q1 2014
1/22/2014
25.830.180.8829.4
Q4 2013
11/7/2013
24.740.220.9027.5
Q3 2013
7/25/2013
23.740.240.8926.7
Q2 2013
4/25/2013
20.420.24NANA
Q1 2013
1/23/2013
20.380.20NANA
Q4 2012
11/8/2012
19.470.21NANA
VIVO Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q4 2022
11/22/2022
31.770.200.8039.7
Q3 2022
8/5/2022
32.500.160.6450.8
Q2 2022
5/6/2022
26.220.662.649.9
Q1 2022
2/4/2022
23.980.351.4017.1
Q4 2021
11/12/2021
20.730.230.9222.5
Q3 2021
8/6/2021
20.630.220.8823.4
Q2 2021
5/7/2021
20.450.562.249.1
Q1 2021
2/5/2021
29.020.652.6011.2
Q4 2020
11/13/2020
16.920.190.7622.3
Q3 2020
8/7/2020
19.320.552.208.8
Q2 2020
5/8/2020
17.490.230.9219.0
Q1 2020
2/7/2020
7.800.100.4019.5
Q4 2019
11/7/2019
8.250.130.5215.9
Q3 2019
7/30/2019
11.980.160.6418.7
Q2 2019
4/30/2019
11.510.190.7615.1
Q1 2019
1/24/2019
16.970.200.8021.2
Q4 2018
11/8/2018
19.630.200.8024.5
Q3 2018
7/31/2018
15.800.180.7221.9
Q2 2018
4/26/2018
14.900.210.8417.7
Q1 2018
1/25/2018
16.200.150.6027.0
Q4 2017
11/9/2017
14.800.150.6024.7
Q3 2017
7/27/2017
14.650.160.6422.9
Q2 2017
4/27/2017
15.000.220.8817.0
Q1 2017
1/25/2017
12.800.150.6021.3
Q4 2016
11/10/2016
17.050.140.5630.4
Q3 2016
7/28/2016
20.000.210.8423.8
Q2 2016
4/28/2016
19.850.240.9620.7
Q1 2016
1/27/2016
18.640.210.8422.2
Q4 2015
11/5/2015
19.950.200.8024.9
Q3 2015
7/23/2015
18.670.220.8821.2
Q2 2015
4/23/2015
18.800.240.9619.6
Q1 2015
1/22/2015
17.340.190.7622.8
Q4 2014
11/6/2014
17.910.200.8022.4
Q3 2014
7/24/2014
20.040.210.8423.9
Q2 2014
4/24/2014
20.570.240.9621.4
Q1 2014
1/22/2014
25.830.180.7235.9
Q4 2013
11/7/2013
24.740.220.8828.1
Q3 2013
7/25/2013
23.740.240.9624.7
Q2 2013
4/25/2013
20.420.240.9621.3
Q1 2013
1/23/2013
20.380.200.8025.5
Q4 2012
11/8/2012
19.470.210.8423.2
Quotes delayed 20 minutes

Email EnvelopeFree VIVO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Meridian Bioscience (VIVO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

VKTX PE Ratio History
VLON PE Ratio History
VNDA PE Ratio History
VOR PE Ratio History
VRAY PE Ratio History
VRCA PE Ratio History
VRDN PE Ratio History
VREX PE Ratio History
VRPX PE Ratio History
VRTX PE Ratio History
On this page we presented the VIVO PE Ratio History information for Meridian Bioscience' stock. The average VIVO PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 22.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average VIVO PE ratio history based on this TTM earnings result method is 20.6.

Let's now compare this VIVO PE ratio history result, against the recent PE: when this page was posted on 1/31/2023, the most recent closing price for VIVO had been 33.97, and the most recent quarterly earnings result, annualized, was 0.8. Meanwhile, the most recent TTM earnings summed to 1.37. From these numbers, we calculate the recent VIVO PE on 1/31/2023 based on annualized quarterly EPS was 42.5. Based on VIVO's history, that recent PE is elevated relative to the historical average, with the recent PE 90.6% higher than the historical average PE across our data set for Meridian Bioscience. Looking at the recent VIVO PE on 1/31/2023 based on TTM EPS, we calculate the ratio at 24.8. Based on VIVO's history, that recent PE is elevated relative to the historical average, with the recent PE 20.4% higher than the historical average PE across our Meridian Bioscience data set with TTM EPS used in the calculation at each period.

Another interesting VIVO PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for VIVO, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for VIVO, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.16, 0.20, 0.35, and 0.66. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.20 and 0.35 — which gives us the median of 0.28. Basically the way to think about this 0.28 number is this: for the trailing four earnings reports, 0.28 marks the "middle ground" number where VIVO has reported a value higher than 0.28 half the time, and has reported a value lower than 0.28 half the time. Annualizing that median value then gets us to 1.12/share, which we use as the denominator in our next PE calculation. With 33.97 as the numerator (as of 1/31/2023), the calculation is then 33.97 / 1.12 = 30.3 as the VIVO PE ratio as of 1/31/2023, based on that annualized median value we calculated.

For self directed investors doing their due diligence on VIVO or any other given stock, valuation analysis for VIVO can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Meridian Bioscience PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for VIVO. Thanks for visiting, and the next time you need to research VIVO PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: Institutional Holders of ERGF, Funds Holding DTC, Funds Holding EQM.

 

VIVO PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.